Steatotic liver disease: a new name to reflect the combined role of alcohol and metabolic dysfunction

被引：6
|
作者：
Krag, Aleksander [1 ,2 ]
Rinella, Mary E. [3 ]
机构：
[1] Odense Univ Hosp, Ctr Liver Res, Dept Gastroenterol & Hepatol, Odense, Denmark
[2] Univ Southern Denmark, Inst Clin Res, Odense, Denmark
[3] Univ Chicago, Pritzker Sch Med, Chicago, IL USA
来源：
NATURE MEDICINE | 2024年 / 30卷 / 04期
关键词：
D O I：
10.1038/s41591-024-02849-3
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Steatotic liver disease is part of a revised nomenclature to replace the term fatty liver disease, but this should also drive forward innovation in research, diagnostics and treatments.
引用
收藏
页码：933 / 936
页数：4
相关论文
共 50 条
  • [1] Steatotic liver disease: a new name to reflect the combined role of alcohol and metabolic dysfunction
    Aleksander Krag
    Mary E. Rinella
    Nature Medicine, 2024, 30 : 933 - 936
  • [2] Steatotic Liver Disease: Metabolic Dysfunction, Alcohol, or Both?
    Staufer, Katharina
    Stauber, Rudolf E.
    BIOMEDICINES, 2023, 11 (08)
  • [3] THE LIPIDOMIC PROFILE DISCRIMINATES BETWEEN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE AND COMBINED METABOLIC DYSFUNCTION- AND ALCOHOL-RELATED STEATOTIC LIVER DISEASE
    Schneider, Carolin Victoria
    Loomba, Rohit
    Huang, Helen
    Raptis, Anastasia
    Creasy, Kate Townsend
    Clusmann, Jan
    Van Haag, Felix
    Luedde, Tom
    Francque, Sven
    Schneider, Kai Markus
    HEPATOLOGY, 2024, 80 : S453 - S454
  • [4] Metabolic dysfunction-associated steatotic liver disease: Time to get familiar with the new name for NAFLD
    Podszun, Maren C.
    NUTRITION RESEARCH, 2024, 126 : 11 - 13
  • [5] Implications of the new nomenclature of steatotic liver disease and definition of metabolic dysfunction-associated steatotic liver disease
    Loomba, Rohit
    Wong, Vincent Wai-Sun
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (02) : 150 - 156
  • [6] Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Polyzos, Stergios A.
    Targher, Giovanni
    CURRENT OBESITY REPORTS, 2024, 13 (02) : 242 - 255
  • [7] The association between alcohol consumption and cardiometabolic factors and liver fibrosis in metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction and alcohol-associated liver disease
    Sogabe, Masahiro
    Okahisa, Toshiya
    Kagawa, Miwako
    Kashihara, Takanori
    Shinomiya, Ryo
    Miyake, Takanori
    Kawaguchi, Tomoyuki
    Yokoyama, Reiko
    Kagemoto, Kaizo
    Kida, Yoshifumi
    Okada, Yasuyuki
    Tomonari, Tetsu
    Kawano, Yutaka
    Sato, Yasushi
    Nakasono, Masahiko
    Takayama, Tetsuji
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (11-12) : 1587 - 1598
  • [8] Role of the Gut Microbiome in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Maher, Salim
    Rajapakse, Jayashi
    El-Omar, Emad
    Zekry, Amany
    SEMINARS IN LIVER DISEASE, 2024, 44 (04) : 457 - 473
  • [9] Steatotic Liver Disease with metabolic Dysfunction - the new Nomenclature for Fatty Liver in the German Context
    Schattenberg, Joern M.
    Tacke, Frank
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2024, 62 (07): : 1074 - 1076
  • [10] Living donor liver transplantation for metabolic dysfunction and alcohol associated/related liver disease versus alcohol associated liver disease:Implications of applying the new steatotic liver disease nomenclature
    Shetty, N.
    Dhampalwar, S.
    Singh, K. A.
    Saraf, N.
    Choudhary, N. S.
    Bhangui, P.
    Rastogi, A.
    Gupta, A.
    Yadav, K.
    Valappil, F. K.
    Chaud-Hary, S.
    Bansal, R.
    Soin, A. S.
    LIVER TRANSPLANTATION, 2024, 30 : 50 - 50
12345